Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gamma-Delta T Cell and CIK Immunotherapy in Gastric Cancer
NCT02585908Phase 2Unknown
- Sponsor
- Beijing DOING Biomedical Technology
- Start
- Dec 2019
- Primary completion
- Dec 2021
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of gamma-delta T cells in gastric cancer (GC), sponsored by Beijing DOING Biomedical Technology. Status: unknown.
02
Drugs
gamma-delta T cells
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02585908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02585908.